GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » Cash And Cash Equivalents

Integrum AB (OSTO:INTEG B) Cash And Cash Equivalents : kr28.36 Mil (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Integrum AB Cash And Cash Equivalents?

Integrum AB's quarterly cash and cash equivalents increased from Jul. 2023 (kr29.87 Mil) to Oct. 2023 (kr33.32 Mil) but then stayed the same from Oct. 2023 (kr33.32 Mil) to Jan. 2024 (kr28.36 Mil).

Integrum AB's annual cash and cash equivalents increased from Apr. 2021 (kr7.66 Mil) to Apr. 2022 (kr75.34 Mil) but then declined from Apr. 2022 (kr75.34 Mil) to Apr. 2023 (kr41.92 Mil).


Integrum AB Cash And Cash Equivalents Historical Data

The historical data trend for Integrum AB's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB Cash And Cash Equivalents Chart

Integrum AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only 10.62 13.06 7.66 75.34 41.92

Integrum AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.33 41.92 29.87 33.32 28.36

Integrum AB Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Integrum AB  (OSTO:INTEG B) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Integrum AB Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Integrum AB's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrum AB (OSTO:INTEG B) Business Description

Traded in Other Exchanges
Address
Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB (OSTO:INTEG B) Headlines

No Headlines